Girard Partners Ltd. Eli Lilly & CO Transaction History

Girard Partners Ltd.

  • $1.06 Billion
  • Q2 2024

A detailed history of Girard Partners Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Girard Partners Ltd. holds 1,754 shares of LLY stock, worth $1.34 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,754
Previous 1,753 0.06%
Holding current value
$1.34 Million
Previous $1.36 Million 16.51%
% of portfolio
0.15%
Previous 0.13%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$724.87 - $909.04 $724 - $909
1 Added 0.06%
1,754 $1.59 Million
Q1 2024

May 13, 2024
SELL
$592.2 - $792.28 $71,064 - $95,073
-120 Reduced 6.41%
1,753 $1.36 Million
Q4 2023

Feb 09, 2024
SELL
$525.19 - $619.13 $35,712 - $42,100
-68 Reduced 3.5%
1,873 $1.09 Million
Q3 2023

Nov 02, 2023
SELL
$434.7 - $599.3 $36,949 - $50,940
-85 Reduced 4.2%
1,941 $1.04 Million
Q2 2023

Aug 15, 2023
SELL
$350.74 - $468.98 $59,625 - $79,726
-170 Reduced 7.74%
2,026 $950,000
Q1 2023

May 12, 2023
BUY
$310.63 - $364.82 $27,956 - $32,833
90 Added 4.27%
2,196 $754,000
Q4 2022

Jan 26, 2023
BUY
$321.55 - $374.67 $192,608 - $224,427
599 Added 39.75%
2,106 $0
Q3 2022

Oct 20, 2022
SELL
$296.48 - $337.87 $14,231 - $16,217
-48 Reduced 3.09%
1,507 $487,000
Q2 2022

Jul 26, 2022
BUY
$278.73 - $327.27 $1,951 - $2,290
7 Added 0.45%
1,555 $504,000
Q1 2022

Apr 27, 2022
BUY
$234.69 - $291.66 $5,867 - $7,291
25 Added 1.64%
1,548 $443,000
Q4 2021

Feb 02, 2022
SELL
$224.85 - $279.04 $22,485 - $27,904
-100 Reduced 6.16%
1,523 $420,000
Q3 2021

Nov 01, 2021
BUY
$221.6 - $272.71 $276,778 - $340,614
1,249 Added 333.96%
1,623 $374,000
Q3 2021

Nov 01, 2021
SELL
$221.6 - $272.71 $325,973 - $401,156
-1,471 Reduced 79.73%
374 $374,000
Q2 2021

Aug 10, 2021
SELL
$180.55 - $233.54 $16,971 - $21,952
-94 Reduced 4.85%
1,845 $423,000
Q1 2021

May 06, 2021
SELL
$164.32 - $212.72 $3,122 - $4,041
-19 Reduced 0.97%
1,939 $362,000
Q4 2020

Feb 02, 2021
SELL
$130.46 - $172.63 $120,284 - $159,164
-922 Reduced 32.01%
1,958 $330,000
Q3 2020

Nov 13, 2020
SELL
$146.22 - $169.13 $64,044 - $74,078
-438 Reduced 13.2%
2,880 $426,000
Q2 2020

Aug 10, 2020
SELL
$136.42 - $164.18 $110,773 - $133,314
-812 Reduced 19.66%
3,318 $544,000
Q1 2020

May 01, 2020
BUY
$119.05 - $147.35 $2,857 - $3,536
24 Added 0.58%
4,130 $572,000
Q4 2019

Feb 03, 2020
BUY
$106.92 - $132.43 $10,798 - $13,375
101 Added 2.52%
4,106 $539,000
Q3 2019

Nov 01, 2019
SELL
$106.79 - $116.16 $103,265 - $112,326
-967 Reduced 19.45%
4,005 $447,000
Q2 2019

Aug 12, 2019
BUY
$110.79 - $129.32 $2,658 - $3,103
24 Added 0.49%
4,972 $550,000
Q1 2019

May 08, 2019
BUY
$111.31 - $131.02 $53,094 - $62,496
477 Added 10.67%
4,948 $642,000
Q4 2018

Feb 11, 2019
SELL
$105.9 - $118.64 $91,285 - $102,267
-862 Reduced 16.16%
4,471 $517,000
Q3 2018

Nov 09, 2018
SELL
$85.86 - $107.31 $194,043 - $242,520
-2,260 Reduced 29.76%
5,333 $572,000
Q2 2018

Aug 07, 2018
BUY
$75.7 - $86.88 $33,762 - $38,748
446 Added 6.24%
7,593 $648,000
Q1 2018

Apr 18, 2018
SELL
$74.21 - $87.6 $71,761 - $84,709
-967 Reduced 11.92%
7,147 $553,000
Q4 2017

Feb 07, 2018
BUY
$81.94 - $87.89 $106,276 - $113,993
1,297 Added 19.03%
8,114 $685,000
Q3 2017

Nov 08, 2017
SELL
$77.07 - $85.54 $16,647 - $18,476
-216 Reduced 3.07%
6,817 $583,000
Q2 2017

Aug 08, 2017
BUY
N/A
7,033
7,033 $579,000

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $727B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Girard Partners Ltd. Portfolio

Follow Girard Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email